Increased expression of SAMHD1 in a subset of HIV-1 elite controllers

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 11, 2014, Pages 3057-3060

  Riveira Muñoz, Eva ^a   Ruiz, Alba ^a   Pauls, Eduardo ^a   Permanyer, Marc ^a   Badia, Roger ^a   Mothe, Beatriz ^a   Crespo, Manel ^b   Clotet, Bonaventura ^a   Brander, Christian ^a,c   Ballana, Ester ^a   Esté, José A ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

P21; Restriction factors; Viral control

Indexed keywords

BIOLOGICAL MARKER; BISPECIFIC ANTIBODY; CD3 ANTIBODY; CD8 ANTIBODY; CELL ANTIBODY; CYCLIN DEPENDENT KINASE INHIBITOR 1A; KI 67 ANTIGEN; MESSENGER RNA; PHOSPHATASE; SAMHD1 PROTEIN; UNCLASSIFIED DRUG; MONOMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; SAMHD1 PROTEIN, HUMAN;

ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LYMPHOCYTE PROLIFERATION; T LYMPHOCYTE ACTIVATION; VIREMIA; VIRUS LOAD; VIRUS REPLICATION; BIOSYNTHESIS; ENZYMOLOGY; GENE EXPRESSION REGULATION; HUMAN IMMUNODEFICIENCY VIRUS 1; PHENOTYPE; PHYSIOLOGY;

GENE EXPRESSION REGULATION, ENZYMOLOGIC; HIV-1; HUMANS; KI-67 ANTIGEN; MONOMERIC GTP-BINDING PROTEINS; PHENOTYPE; VIRUS REPLICATION;

EID: 84926504757     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku276     Document Type: Article

References (22)

1. Ballana E, Este JA. Insights from host genomics into HIV infection and disease: identification of host targets for drug development. Antiviral Res 2013; 100: 473-86.
2. Walker BD, Yu XG. Unravelling the mechanisms of durable control of HIV-1. Nature Rev Immunol 2013; 13: 487-98.
3. Ciuffi A, Bleiber G, Munoz M et al. Entry and transcription as key determinants of differences in CD4 T-cell permissiveness to human immunodeficiency virus type 1 infection. J Virol 2004; 78: 10747-54.
4. Chen H, Li C, Huang J et al. CD4+ Tcells from elite controllers resist HIV-1 infection by selective upregulation of p21. J Clin Invest 2011; 121: 1549-60.
5. Saez-Cirion A, Hamimi C, Bergamaschi A et al. Restriction of HIV-1 replication in macrophages and CD4+Tcells from HIV controllers. Blood 2011; 118: 955-64.
6. Zaunders J, van Bockel D. Innate and adaptive immunity in long-term non-progression in HIV disease. Frontiers Immunol 2013; 4: 95.
7. Autran B, Descours B, Avettand-Fenoel V et al. Elite controllers as a model of functional cure. Curr Opin HIV AIDS 2011; 6: 181-7.
8. Baldauf HM, Pan X, Erikson E et al. SAMHD1 restricts HIV-1 infection in resting CD4+ T cells. Nat Med 2012; 18: 1682-9.
9. Goldstone DC, Ennis-Adeniran V, Hedden JJ et al. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 2011; 480: 379-82.
10. Lahouassa H, Daddacha W, Hofmann H et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol 2012; 13: 223-8.
11. Pauls E, Ballana E, Este JA. Nucleotide embargo by SAMHD1: a strategy to block retroviral infection. Antiviral Res 2013; 97: 180-2.
12. Rehwinkel J, Maelfait J, Bridgeman A et al. SAMHD1-dependent retroviral control and escape in mice. EMBO J 2013; 32: 2454-62.
13. Allouch A, David A, Amie SM et al. p21-mediated RNR2 repression restricts HIV-1 replication in macrophages by inhibiting dNTP biosynthesis pathway. Proc Natl Acad Sci USA 2013; 110: E3997-4006.
14. Pauls E, Ruiz A, Riveira-Muñoz E et al. p21 regulates the HIV-1 restriction factor SAMHD1. Proc Natl Acad Sci USA; 2014; 111: E1322-4.
15. Park J, Lim CH, Ham S et al. Genome-wide analysis of histone modifications in latently HIV-1 infected T cells. AIDS 2014; 28: 1719-28.
16. Mohri H, Perelson AS, Tung K et al. Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. J Exp Med 2001; 194: 1277-87.
17. Cribier A, Descours B, Valadão AL et al. Phosphorylation of SAMHD1 by cyclin A2/CDK1 regulates its restriction activity toward HIV-1. Cell Rep 2013; 3: 1036-43.
18. White TE, Brandariz-Nuñez A, Valle-Casuso JC et al. The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation. Cell Host Microbe 2013; 13: 441-51.
19. Pauls E, Ruiz A, Riveira-Muñoz E et al. Cell cycle control and HIV-1 susceptibility are linked by a CDK6-dependent CDK2 phosphorylation of SAMHD1 in myeloid and lymphoid cells. J Immunol 2014; doi:10.4049/jimmunol.1400873.
20. Raposo RAS, Abdel-Mohsen M, Holditch SJ et al. Increased expression of intrinsic antiviral genes in HLA-B*57-positive individuals. J Leukoc Biol 2013; 94: 1051-9.
21. Ballana E, Ruiz-de Andres A, Mothe B et al. Differential prevalence of the HLA-C-35 CC genotype among viremic long term non-progressor and elite controller HIV+ individuals. Immunobiology 2012; 217: 889-94.
22. Hollenbaugh JA, Gee P, Baker J et al. Host factor SAMHD1 restricts DNA viruses in non-dividing myeloid cells. PLoS Pathog 2013; 9: e1003481.